Mark A. Demitrack, MD
- 7Articles
- 35.6KReads
- 2002–2014Active
- 31Collaborators
- 130Citations
About
Mark A. Demitrack, MD, has published extensively on major depressive disorder (MDD), focusing on treatments such as transcranial magnetic stimulation and pharmacotherapy. His work includes clinical trials and observational studies evaluating the safety, efficacy, and durability of transcranial magnetic stimulation for pharmacoresistant depression. He has also contributed to research on duloxetine as a treatment for MDD and explored potential improvements to monoamine-based therapies. His publications span from 2002 to 2014 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
